BCCIP is required for the nuclear localization of the p21 protein

Cell Cycle

Volumn 8, Issue 18, 2009, Pages 3023-3028

  Fan, Jinjiang ^a   Wray, Justin ^b   Meng, Xiangbing ^b   Shen, Zhiyuan ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

BCCIP; Checkpoint; FRET; G1 S; p21

Indexed keywords

BRCA2 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PROTEIN BCCIPALPHA; PROTEIN BCCIPBETA; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL FATE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DNA DAMAGE; DOWN REGULATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

EID: 70349278429     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.18.9622     Document Type: Article

References (19)

1. Gu Y, Turck CW, Morgan DO. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 1993; 366:707-710 (Pubitemid 24036022)
2. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-825
3. Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994; 211:90-98 (Pubitemid 24167339)
4. 1 cyclin-dependent kinases. Cell 1993; 75:805-816
5. Waga S, Hannon GJ, Beach D, Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994; 369:574-578 (Pubitemid 24192528)
6. Wyllie FS, Haughton MF, Bond JA, Rowson JM, Jones CJ, Wynford-Thomas D. S phase cell cycle arrest following DNA damage is independent of the p53/p21(WAF1) signalling pathway. Oncogene 1996; 12:1077-1082 (Pubitemid 126422956)
7. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, et al. New functional activities for the p21 family of CDK inhibitors. Genes Dev 1997; 11:847-862 (Pubitemid 27175292)
8. WAF1 and IAP gene family ILP. Oncogene 1998; 17:931-939
9. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumuro K, et al. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J 1999; 18:1223-1234 (Pubitemid 29110307)
10. Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase. J Biol Chem 2000; 275:31145-31154
11. Liu J, Yuan Y, Huan J, Shen Z. Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2. Oncogene 2001; 20:336-345 (Pubitemid 32142323)
12. 1 to S cell cycle progression by BCCIP beta. Cell Cycle 2004; 3:343-348
13. Meng X, Liu J, Shen Z. Genomic structure of the human BCCIP gene and its expression in cancer. Gene 2003; 302:139-146 (Pubitemid 36078405)
14. Waf1/Cip1. Cell Cycle 2004; 3:1457-1462
15. Lu H, Guo X, Meng X, Liu J, Allen C, Wray J, et al. The BRCA2-interacting protein BCCIP functions in RAD51 and BRCA2 focus formation and homologous recombinational repair. Mol Cell Biol 2005; 25:1949-1957 (Pubitemid 40280157)
16. Lu H, Yue J, Meng X, Nickoloff JA, Shen Z. BCCIP regulates homologous recombination by distinct domains and suppresses spontaneous DNA damage. Nucleic Acids Res 2007; 35:7160-7170
17. van Rheenen J, Langeslag M, Jalink K. Correcting confocal acquisition to optimize imaging of fluorescence resonance energy transfer by sensitized emission. Biophys J 2004; 86:2517-2529 (Pubitemid 38524438)
18. Meng X, Fan J, Shen Z. Roles of BCCIP in chromosome stability and cytokinesis. Oncogene 2007; 26:6253-6260 (Pubitemid 47462109)
19. Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol 2001; 3:245-252